The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Subscribe To Our Newsletter & Stay Updated
